avrg: SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SIN3A
|
ENSG00000169375.11 | SIN3 transcription regulator family member A |
CHD1
|
ENSG00000153922.6 | chromodomain helicase DNA binding protein 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
CHD1 | hg19_v2_chr5_-_98262240_98262240 | 0.73 | 2.6e-04 | Click! |
SIN3A | hg19_v2_chr15_-_75748115_75748126 | 0.66 | 1.4e-03 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 12.9 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
3.0 | 12.1 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
2.1 | 6.4 | GO:0007387 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
1.8 | 5.4 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
1.5 | 4.6 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
1.5 | 5.9 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
1.4 | 4.1 | GO:0019858 | cytosine metabolic process(GO:0019858) |
1.2 | 3.7 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
1.2 | 5.8 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
1.2 | 17.4 | GO:0060613 | fat pad development(GO:0060613) |
1.1 | 3.4 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
1.1 | 1.1 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
1.1 | 2.2 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
1.1 | 4.4 | GO:0035978 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
1.1 | 3.2 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
1.0 | 4.0 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
1.0 | 1.0 | GO:0021511 | spinal cord patterning(GO:0021511) |
1.0 | 3.0 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
0.9 | 3.8 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.9 | 2.8 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.9 | 1.8 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.9 | 3.5 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.9 | 5.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.8 | 5.0 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.8 | 2.4 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.8 | 5.5 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.8 | 8.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.8 | 0.8 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
0.7 | 3.7 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.7 | 3.0 | GO:0009956 | radial pattern formation(GO:0009956) |
0.7 | 3.6 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.7 | 2.2 | GO:0010160 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.7 | 2.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.7 | 5.6 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.7 | 2.1 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.7 | 2.7 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.7 | 0.7 | GO:0007032 | endosome organization(GO:0007032) |
0.7 | 0.7 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.7 | 6.5 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.6 | 3.2 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.6 | 1.9 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
0.6 | 2.6 | GO:0060594 | mammary gland specification(GO:0060594) |
0.6 | 3.8 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.6 | 1.9 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.6 | 3.8 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.6 | 1.9 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.6 | 0.6 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.6 | 3.1 | GO:0021623 | optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.6 | 4.3 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.6 | 2.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.6 | 1.2 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.6 | 5.5 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.6 | 6.0 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
0.6 | 1.8 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.6 | 3.6 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.6 | 1.8 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.6 | 2.4 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
0.6 | 1.7 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
0.6 | 2.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.6 | 4.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.6 | 2.9 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.6 | 2.3 | GO:0003169 | coronary vein morphogenesis(GO:0003169) |
0.6 | 2.3 | GO:1990927 | vesicle-mediated cholesterol transport(GO:0090119) calcium ion regulated lysosome exocytosis(GO:1990927) |
0.6 | 1.7 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
0.6 | 1.1 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
0.5 | 2.2 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.5 | 1.6 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.5 | 3.8 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.5 | 7.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.5 | 1.6 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.5 | 2.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.5 | 0.5 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.5 | 1.6 | GO:0003249 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
0.5 | 7.2 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.5 | 7.6 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.5 | 1.5 | GO:1903248 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.5 | 2.5 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.5 | 2.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.5 | 0.5 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.5 | 1.4 | GO:0021503 | neural fold bending(GO:0021503) |
0.5 | 7.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.5 | 2.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 0.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.5 | 0.9 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.5 | 1.4 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.5 | 1.4 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.5 | 1.4 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.5 | 2.8 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.5 | 3.2 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.5 | 8.6 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.5 | 1.4 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.4 | 1.8 | GO:0021897 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
0.4 | 1.3 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.4 | 1.3 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
0.4 | 0.4 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.4 | 3.4 | GO:0030578 | PML body organization(GO:0030578) |
0.4 | 3.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 1.7 | GO:0001897 | cytolysis by symbiont of host cells(GO:0001897) |
0.4 | 1.3 | GO:1903515 | calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
0.4 | 1.7 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.4 | 1.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.4 | 4.6 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.4 | 2.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.4 | 1.6 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
0.4 | 1.6 | GO:0061551 | trigeminal ganglion development(GO:0061551) |
0.4 | 1.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 2.4 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.4 | 3.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.4 | 2.4 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.4 | 3.1 | GO:0061197 | fungiform papilla morphogenesis(GO:0061197) |
0.4 | 1.2 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
0.4 | 1.5 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.4 | 2.3 | GO:1901909 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.4 | 1.9 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.4 | 2.7 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.4 | 1.5 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.4 | 1.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.4 | 6.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.4 | 0.4 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.4 | 2.6 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.4 | 0.7 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.4 | 2.2 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.4 | 1.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.4 | 1.8 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.4 | 1.5 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.4 | 1.1 | GO:1990709 | maintenance of synapse structure(GO:0099558) presynaptic active zone organization(GO:1990709) |
0.4 | 1.8 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.4 | 1.4 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.4 | 2.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 1.1 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.4 | 2.9 | GO:0008354 | germ cell migration(GO:0008354) |
0.4 | 3.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.4 | 2.8 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.4 | 0.4 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.4 | 1.1 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.4 | 6.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.4 | 0.4 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.3 | 1.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 0.7 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.3 | 0.7 | GO:0002188 | translation reinitiation(GO:0002188) |
0.3 | 1.7 | GO:0045786 | negative regulation of cell cycle(GO:0045786) |
0.3 | 3.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.3 | 2.0 | GO:0030421 | defecation(GO:0030421) |
0.3 | 1.0 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.3 | 5.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.3 | 1.0 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.3 | 2.0 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.3 | 0.7 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.3 | 1.0 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.3 | 2.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 3.3 | GO:0051013 | microtubule severing(GO:0051013) |
0.3 | 1.0 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.3 | 1.3 | GO:0007538 | primary sex determination(GO:0007538) |
0.3 | 1.9 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.3 | 1.0 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.3 | 1.6 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.3 | 3.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 2.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 2.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 0.9 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.3 | 0.9 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 0.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.3 | 0.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.3 | 1.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 3.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 0.9 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.3 | 0.9 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.3 | 3.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 0.9 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.3 | 2.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 5.9 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.3 | 0.9 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.3 | 1.7 | GO:1990834 | response to odorant(GO:1990834) |
0.3 | 0.9 | GO:0098761 | interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
0.3 | 0.6 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.3 | 4.0 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.3 | 0.9 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.3 | 3.7 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.3 | 0.8 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.3 | 0.3 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.3 | 0.8 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.3 | 0.6 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.3 | 1.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.3 | 2.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.3 | 2.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 1.1 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.3 | 0.8 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.3 | 5.8 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.3 | 1.1 | GO:0044334 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.3 | 0.6 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.3 | 3.9 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.3 | 0.5 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.3 | 3.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 3.8 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.3 | 2.9 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.3 | 0.3 | GO:0044774 | mitotic DNA damage checkpoint(GO:0044773) mitotic DNA integrity checkpoint(GO:0044774) |
0.3 | 1.3 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.3 | 4.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 1.3 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.3 | 4.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 1.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 1.3 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.3 | 3.1 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.3 | 0.8 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.3 | 2.6 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.3 | 0.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.3 | 1.0 | GO:1904978 | regulation of endosome organization(GO:1904978) |
0.3 | 1.0 | GO:0048880 | sensory system development(GO:0048880) |
0.3 | 1.5 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
0.3 | 0.8 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.3 | 4.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 2.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 1.0 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
0.2 | 6.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 1.0 | GO:1904387 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
0.2 | 2.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 1.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 3.7 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 | 1.2 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.2 | 1.5 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 1.9 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.2 | 1.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.2 | 1.4 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.2 | 0.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 2.8 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.7 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 4.4 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 1.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 1.2 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.2 | 1.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 2.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 0.9 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.2 | 5.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 0.7 | GO:0035261 | external genitalia morphogenesis(GO:0035261) |
0.2 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 2.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 2.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 2.9 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.2 | 0.5 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 0.2 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 0.4 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.2 | 0.9 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.2 | 2.2 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.7 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.2 | 1.1 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 0.7 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.2 | 0.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.2 | 0.7 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 1.3 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.2 | 0.6 | GO:1904303 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.2 | 2.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 1.9 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 0.6 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.2 | 0.4 | GO:2000683 | regulation of cellular response to X-ray(GO:2000683) |
0.2 | 3.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 1.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 1.7 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.6 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
0.2 | 0.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 1.8 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.2 | 0.8 | GO:1904647 | response to rotenone(GO:1904647) |
0.2 | 3.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 1.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 1.0 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.2 | 0.6 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.2 | 0.4 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.2 | 0.8 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.2 | 1.8 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 1.0 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.2 | 1.2 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.2 | 1.9 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 1.6 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 1.0 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.2 | 4.6 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) |
0.2 | 1.9 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.2 | 2.3 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.2 | 0.8 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.8 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.2 | 0.8 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.2 | 0.8 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 0.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.2 | 0.4 | GO:0006788 | heme oxidation(GO:0006788) |
0.2 | 0.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.2 | 3.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.2 | 1.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.6 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.2 | 1.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.6 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.2 | 3.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 1.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 2.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 3.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.4 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.2 | 0.4 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.2 | 2.7 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 0.5 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
0.2 | 0.4 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.2 | 0.5 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
0.2 | 4.7 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 1.4 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.2 | 1.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 3.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 3.0 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 0.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.2 | 0.5 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.2 | 2.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.4 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
0.2 | 1.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.7 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 0.4 | GO:0036292 | DNA rewinding(GO:0036292) |
0.2 | 0.9 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
0.2 | 0.7 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.2 | 0.2 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.2 | 1.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.2 | 2.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.2 | 0.5 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 1.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 0.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 0.7 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.2 | 0.9 | GO:1902904 | late endosomal microautophagy(GO:0061738) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.2 | 0.3 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.2 | 0.7 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.2 | 0.3 | GO:0048382 | mesendoderm development(GO:0048382) |
0.2 | 4.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 5.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.2 | 0.7 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 5.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.2 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
0.2 | 0.3 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.2 | 1.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.2 | GO:0044117 | growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) |
0.2 | 0.2 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 0.5 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.2 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.8 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.3 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.2 | 2.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 1.0 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.2 | 0.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.2 | GO:1901204 | regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
0.2 | 0.2 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.2 | 2.5 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 1.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 2.6 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.2 | 0.5 | GO:0008057 | eye pigment granule organization(GO:0008057) |
0.2 | 0.7 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 1.2 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.2 | 1.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 1.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.2 | 0.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 3.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.8 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.2 | 1.6 | GO:1903011 | negative regulation of bone development(GO:1903011) negative regulation of osteoclast development(GO:2001205) |
0.2 | 0.6 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 1.8 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.2 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 0.3 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.2 | 1.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 0.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 1.1 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.2 | 0.6 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.2 | 0.3 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.2 | 0.5 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.2 | 2.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.3 | GO:0061145 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
0.2 | 2.7 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 0.3 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.2 | 1.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 0.5 | GO:0070781 | response to biotin(GO:0070781) |
0.2 | 0.6 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.2 | 2.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 0.6 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.2 | 1.7 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.2 | 2.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 0.9 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.2 | 0.6 | GO:0016598 | protein arginylation(GO:0016598) |
0.2 | 1.8 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.2 | 0.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 0.9 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.2 | 0.3 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
0.2 | 2.3 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
0.1 | 0.9 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.1 | 0.6 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 1.3 | GO:0006623 | protein targeting to vacuole(GO:0006623) |
0.1 | 4.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 2.8 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 1.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.1 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 2.6 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 1.0 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.1 | 1.3 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.4 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.1 | 0.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 1.1 | GO:0031638 | zymogen activation(GO:0031638) |
0.1 | 9.9 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.3 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.1 | 0.7 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 0.3 | GO:1903364 | positive regulation of cellular protein catabolic process(GO:1903364) |
0.1 | 1.0 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.1 | 0.8 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 1.5 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.4 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.1 | 0.6 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.1 | 0.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 1.7 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.1 | 0.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 1.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 1.0 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.1 | 0.7 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 0.7 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.9 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.3 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.1 | 0.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.5 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.1 | 0.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.5 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.1 | 0.5 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.1 | 2.9 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 3.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.9 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.5 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.1 | 0.8 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.8 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.6 | GO:1904448 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.1 | 9.0 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.1 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.1 | 0.3 | GO:0001300 | chronological cell aging(GO:0001300) |
0.1 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 1.0 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.1 | 0.3 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.1 | 0.3 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 0.8 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.8 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.1 | 0.4 | GO:0043491 | protein kinase B signaling(GO:0043491) |
0.1 | 0.4 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.1 | 1.0 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.1 | 0.6 | GO:1903613 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
0.1 | 0.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.1 | 0.9 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.2 | GO:0051645 | Golgi localization(GO:0051645) |
0.1 | 0.5 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 1.9 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.2 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 1.0 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.1 | 5.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 10.3 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 1.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.2 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.1 | 0.2 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.1 | 0.4 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.1 | 0.6 | GO:2000481 | positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
0.1 | 5.8 | GO:1902100 | negative regulation of mitotic metaphase/anaphase transition(GO:0045841) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) |
0.1 | 1.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 4.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.4 | GO:0042445 | hormone metabolic process(GO:0042445) |
0.1 | 0.5 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.1 | 1.2 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.1 | 0.8 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.8 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.5 | GO:0043543 | protein acylation(GO:0043543) |
0.1 | 1.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 2.9 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.1 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.3 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.1 | 2.4 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.9 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.9 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.1 | 1.9 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.1 | 0.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.7 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 2.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 1.4 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 4.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.5 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.7 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 0.6 | GO:0031054 | pre-miRNA processing(GO:0031054) miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) small RNA loading onto RISC(GO:0070922) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.1 | 0.3 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.1 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.2 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.1 | 2.3 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.7 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 1.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.7 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.1 | 1.2 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
0.1 | 0.7 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.4 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.1 | 1.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.4 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.2 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 2.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.2 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.1 | 0.7 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.1 | 0.2 | GO:0070638 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.1 | 0.6 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 7.2 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.7 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 1.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 1.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.2 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 2.8 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.4 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle morphogenesis(GO:0071600) |
0.1 | 0.4 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.1 | 1.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 2.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.5 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.1 | 0.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 1.4 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 4.4 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 1.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.3 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.1 | 0.2 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 1.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.2 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 | 0.8 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 0.4 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.9 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 0.5 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.6 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 1.2 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.1 | 0.3 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.1 | 0.5 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.1 | 0.3 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.3 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.1 | 0.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 1.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.2 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.1 | 0.6 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.1 | 2.0 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 7.0 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 3.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.1 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.1 | 1.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 1.3 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 1.0 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 2.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 1.4 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 1.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 1.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.4 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.2 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.1 | 0.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.3 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.1 | 2.1 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.5 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.1 | 0.5 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.1 | 3.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.9 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 2.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.6 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 1.2 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 1.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.5 | GO:1902164 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.1 | 0.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 1.0 | GO:0048296 | regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.1 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.3 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
0.1 | 0.9 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.1 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 2.6 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 1.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.7 | GO:0007045 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
0.1 | 1.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.3 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.1 | 5.3 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 1.0 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.2 | GO:0071317 | cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
0.1 | 1.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 1.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 2.0 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.1 | 0.3 | GO:0046959 | habituation(GO:0046959) |
0.1 | 1.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.7 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.9 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 1.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.2 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.9 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.2 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.1 | 1.0 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 1.3 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 0.2 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.1 | 0.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.1 | 5.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.1 | 0.2 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.1 | 0.3 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.1 | 0.4 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.2 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.7 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 1.2 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.1 | 1.1 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.1 | 0.2 | GO:0097056 | selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
0.1 | 0.4 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.1 | 1.9 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 7.1 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.1 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.1 | 0.5 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 9.7 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.8 | GO:0072665 | protein localization to vacuole(GO:0072665) |
0.1 | 0.3 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.1 | 2.0 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.1 | 0.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.2 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.3 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.5 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
0.1 | 0.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.1 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.1 | 0.7 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.1 | 14.3 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 1.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.2 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.1 | 1.1 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.1 | 0.7 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 2.0 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 1.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 1.3 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.1 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.1 | 0.4 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.1 | 0.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.7 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 1.0 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 1.5 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 1.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 1.0 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.5 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.1 | 2.9 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.1 | 0.3 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.8 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 1.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 0.9 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 1.8 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 1.3 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.5 | GO:0015824 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
0.1 | 0.2 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.1 | 0.6 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
0.1 | 7.0 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 2.4 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.2 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.1 | 0.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 8.1 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.7 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.1 | 1.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 1.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.2 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
0.1 | 0.3 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.1 | 1.4 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.7 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 1.1 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.5 | GO:0043473 | pigmentation(GO:0043473) |
0.1 | 0.4 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 1.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.9 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 1.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.9 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.1 | 2.8 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.1 | GO:1902749 | regulation of cell cycle G2/M phase transition(GO:1902749) |
0.1 | 0.8 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.1 | 0.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.1 | 0.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 0.3 | GO:0030522 | intracellular receptor signaling pathway(GO:0030522) |
0.1 | 0.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.8 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.4 | GO:0006231 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
0.1 | 0.2 | GO:1902415 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
0.1 | 0.5 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 1.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.1 | 0.4 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.1 | 0.6 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.1 | 0.1 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 0.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 1.7 | GO:1990090 | cellular response to nerve growth factor stimulus(GO:1990090) |
0.1 | 1.2 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.2 | GO:0097178 | ruffle assembly(GO:0097178) |
0.1 | 0.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 0.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 1.7 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.2 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.2 | GO:0016236 | macroautophagy(GO:0016236) |
0.1 | 0.6 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 1.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.2 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.1 | 0.1 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
0.1 | 1.3 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.2 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 0.9 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.1 | GO:0021761 | limbic system development(GO:0021761) |
0.1 | 0.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.4 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.1 | 0.3 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.1 | 1.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.1 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.1 | 0.2 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.1 | 0.5 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.1 | GO:0051458 | corticotropin secretion(GO:0051458) |
0.1 | 0.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 1.4 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 1.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.1 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.1 | 0.1 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
0.1 | 0.1 | GO:0048627 | myoblast development(GO:0048627) |
0.1 | 1.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.1 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.1 | 0.5 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.1 | 0.3 | GO:2000691 | regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.1 | 1.2 | GO:0006294 | nucleotide-excision repair, preincision complex assembly(GO:0006294) |
0.1 | 1.0 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.2 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.2 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.1 | 0.3 | GO:0002001 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
0.1 | 0.5 | GO:0030336 | negative regulation of cell migration(GO:0030336) |
0.1 | 0.8 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.2 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
0.1 | 0.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.2 | GO:0006775 | fat-soluble vitamin metabolic process(GO:0006775) vitamin D metabolic process(GO:0042359) |
0.1 | 1.0 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.0 | 0.3 | GO:0051383 | kinetochore organization(GO:0051383) |
0.0 | 0.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 1.7 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.0 | 0.1 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.0 | 0.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.1 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.0 | 0.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.8 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.0 | 0.2 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 1.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.1 | GO:0072579 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.0 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 1.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.3 | GO:1990539 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.0 | 0.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:1901383 | negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
0.0 | 0.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.3 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.5 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.2 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.0 | 0.2 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.0 | 0.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.4 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.4 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 1.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.5 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.0 | 0.3 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) regulation of nonmotile primary cilium assembly(GO:1902855) |
0.0 | 0.0 | GO:0043380 | memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) |
0.0 | 0.4 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.0 | 0.1 | GO:0015870 | acetylcholine transport(GO:0015870) |
0.0 | 0.2 | GO:0035733 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
0.0 | 0.2 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
0.0 | 1.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 4.3 | GO:0019079 | viral genome replication(GO:0019079) |
0.0 | 0.2 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.0 | 0.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.0 | 0.2 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.2 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.1 | GO:1903170 | negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.0 | 0.4 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.0 | 1.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 1.3 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.2 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.2 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.4 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.1 | GO:0075528 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.0 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.8 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.2 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.1 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.0 | 0.3 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.1 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.0 | 0.2 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
0.0 | 0.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.2 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.0 | 0.0 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.0 | 0.5 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.0 | 0.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.3 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.0 | GO:0032213 | regulation of telomere maintenance via semi-conservative replication(GO:0032213) negative regulation of telomere maintenance via semi-conservative replication(GO:0032214) negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
0.0 | 0.2 | GO:0072658 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.0 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.0 | 0.1 | GO:0071469 | sensory perception of touch(GO:0050975) detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) cellular response to alkaline pH(GO:0071469) |
0.0 | 0.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.6 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.4 | GO:0051494 | negative regulation of cytoskeleton organization(GO:0051494) |
0.0 | 0.1 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
0.0 | 0.0 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 3.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.2 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.0 | 0.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.2 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
0.0 | 0.6 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.1 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.0 | 0.0 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
0.0 | 0.1 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.0 | 0.6 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.0 | 0.3 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.0 | 0.0 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.0 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.0 | 3.2 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.5 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 4.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.0 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.4 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.0 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.7 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.4 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.3 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.0 | 0.4 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.1 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.0 | 0.3 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.0 | 0.5 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.1 | GO:0046661 | male sex differentiation(GO:0046661) |
0.0 | 0.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.0 | 0.1 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.0 | 0.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.0 | GO:0071878 | negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
0.0 | 0.4 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:0042418 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
0.0 | 0.3 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.2 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
0.0 | 0.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 0.0 | GO:2001056 | positive regulation of cysteine-type endopeptidase activity(GO:2001056) |
0.0 | 0.4 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.1 | GO:1903980 | positive regulation of microglial cell activation(GO:1903980) |
0.0 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.0 | 0.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.0 | 0.1 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 2.1 | GO:0097581 | lamellipodium organization(GO:0097581) |
0.0 | 0.3 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.1 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
0.0 | 0.2 | GO:0070778 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
0.0 | 0.7 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.0 | 0.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.0 | 0.0 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 | 0.0 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.1 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.1 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
0.0 | 0.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) negative regulation of gastric acid secretion(GO:0060455) |
0.0 | 0.1 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.4 | GO:0006913 | nucleocytoplasmic transport(GO:0006913) |
0.0 | 0.4 | GO:0044070 | regulation of anion transport(GO:0044070) |
0.0 | 0.2 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.1 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
0.0 | 0.1 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 1.0 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
0.0 | 5.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.2 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.0 | 0.3 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.1 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.0 | 0.7 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.7 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.0 | 0.4 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.3 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.3 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.0 | 0.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.0 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 1.5 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.4 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.3 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.0 | 0.5 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.6 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.0 | 0.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.2 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.0 | 0.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.6 | GO:0007130 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.0 | 0.0 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.0 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.3 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.1 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
0.0 | 0.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
0.0 | 0.1 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 | 0.0 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.0 | 0.3 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.1 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.0 | 0.3 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.0 | 0.1 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.0 | 0.1 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.3 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.8 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.4 | GO:2001273 | regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.0 | 0.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.0 | GO:1902903 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) regulation of fibril organization(GO:1902903) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.0 | 0.1 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.2 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.0 | 0.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.0 | 0.1 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.0 | 0.4 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.1 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.0 | 0.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.1 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.0 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.0 | 0.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.1 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.2 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.6 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 0.1 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.1 | GO:0045453 | bone resorption(GO:0045453) |
0.0 | 0.1 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.0 | 0.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 0.3 | GO:0051607 | defense response to virus(GO:0051607) |
0.0 | 0.5 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.0 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.0 | 0.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.0 | 0.0 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.0 | 0.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.2 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 0.1 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.0 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.0 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.0 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.0 | 0.1 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.0 | 0.0 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.0 | 0.1 | GO:0033008 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 0.0 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.0 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.0 | 0.5 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.0 | 0.0 | GO:0034109 | homotypic cell-cell adhesion(GO:0034109) |
0.0 | 1.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.0 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.0 | 0.5 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.0 | 0.1 | GO:0071231 | cellular response to folic acid(GO:0071231) |
0.0 | 0.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.2 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.1 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.0 | 0.0 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.0 | 0.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.0 | 0.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.0 | 0.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.0 | 0.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.1 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.0 | 0.0 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.0 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.0 | GO:0036269 | swimming behavior(GO:0036269) |
0.0 | 0.5 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.9 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.0 | 0.0 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.0 | 0.0 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.0 | 0.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.0 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.0 | 0.1 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.0 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
0.0 | 0.2 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.0 | 0.1 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.0 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.0 | 0.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 5.5 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
1.3 | 12.6 | GO:0005955 | calcineurin complex(GO:0005955) |
1.1 | 3.4 | GO:0018444 | translation release factor complex(GO:0018444) |
0.8 | 2.4 | GO:1902737 | dendritic filopodium(GO:1902737) |
0.8 | 0.8 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.7 | 2.2 | GO:0075341 | host cell PML body(GO:0075341) |
0.6 | 1.9 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
0.6 | 4.3 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.5 | 1.6 | GO:1990032 | parallel fiber(GO:1990032) |
0.5 | 6.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.5 | 0.5 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.5 | 5.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.5 | 1.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 7.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.5 | 12.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 3.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 12.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.4 | 0.8 | GO:0089701 | U2AF(GO:0089701) |
0.4 | 0.4 | GO:0070993 | translation preinitiation complex(GO:0070993) |
0.4 | 4.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 2.9 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 1.4 | GO:0031251 | PAN complex(GO:0031251) |
0.3 | 3.8 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 4.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 2.7 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.3 | 0.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 6.4 | GO:0097227 | sperm annulus(GO:0097227) |
0.3 | 1.0 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.3 | 1.3 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.3 | 2.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 1.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 8.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 8.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 3.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 0.9 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.3 | 4.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.3 | 1.5 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.3 | 2.4 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.3 | 3.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.3 | 0.6 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 4.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.3 | 6.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 2.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 1.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.3 | 0.8 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.3 | 6.5 | GO:0097386 | glial cell projection(GO:0097386) |
0.3 | 1.3 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.3 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
0.3 | 2.4 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 3.7 | GO:0001939 | female pronucleus(GO:0001939) |
0.3 | 1.5 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.3 | 1.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 1.0 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.2 | 1.2 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 1.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 35.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 3.7 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.7 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 1.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.2 | 1.4 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.2 | 1.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 3.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 1.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 4.8 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.2 | 2.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.2 | 2.4 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 0.7 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.2 | 2.4 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.2 | 0.6 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.2 | 7.8 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.6 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 0.8 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.2 | 3.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 2.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 1.2 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.2 | 3.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.6 | GO:0008623 | CHRAC(GO:0008623) |
0.2 | 1.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.2 | 1.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 1.7 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.6 | GO:0009346 | citrate lyase complex(GO:0009346) |
0.2 | 1.1 | GO:0031673 | H zone(GO:0031673) |
0.2 | 5.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.6 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.2 | 3.1 | GO:0090544 | BAF-type complex(GO:0090544) |
0.2 | 0.7 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 1.1 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 2.8 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 1.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.2 | 0.7 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.2 | 0.5 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.2 | 0.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 1.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 0.9 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.2 | 0.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 2.0 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.2 | 0.3 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.2 | 0.8 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.2 | 1.2 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.2 | 1.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 1.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 1.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 3.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 1.3 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.2 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 1.3 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 1.0 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 0.8 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 26.8 | GO:0016605 | PML body(GO:0016605) |
0.2 | 1.4 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.2 | 0.9 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.5 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.2 | 7.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.4 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 11.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 1.2 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 1.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 1.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.7 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 1.7 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 2.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.7 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 2.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.1 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 1.9 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 4.7 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 2.5 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 2.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 2.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.4 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.1 | 0.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.5 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.1 | 2.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.6 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.1 | 8.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 4.5 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 4.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.9 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.1 | 4.1 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 5.2 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 1.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.4 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.1 | 0.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 3.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 2.5 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 1.0 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.1 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 1.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 1.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 1.0 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 2.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.4 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.1 | 0.7 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 5.0 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 1.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.2 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.1 | 0.3 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.1 | 1.3 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.8 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.1 | GO:0032302 | MutSbeta complex(GO:0032302) |
0.1 | 0.2 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 9.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 4.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 1.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.5 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 0.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 0.6 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.1 | 4.0 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 0.5 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.1 | 1.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 3.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 7.0 | GO:0002102 | podosome(GO:0002102) |
0.1 | 1.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.8 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 1.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 4.0 | GO:1990752 | microtubule end(GO:1990752) |
0.1 | 0.3 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.1 | 0.7 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 2.0 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 1.5 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 2.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.5 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 0.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.6 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 1.2 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 1.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.7 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 3.2 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.4 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.1 | 1.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 2.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.2 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.1 | 0.6 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 1.6 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 0.9 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 3.3 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.6 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 3.4 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 2.3 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 5.7 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.8 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.8 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.9 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 1.5 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 0.2 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.1 | 1.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 9.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 1.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.8 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 9.5 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 5.9 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 1.7 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 33.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.1 | GO:1990234 | transferase complex(GO:1990234) |
0.1 | 0.6 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 1.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.6 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 11.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 1.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.9 | GO:0030017 | sarcomere(GO:0030017) |
0.1 | 1.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.7 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.1 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.1 | 4.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 5.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.5 | GO:0043292 | contractile fiber(GO:0043292) |
0.1 | 0.5 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.2 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 1.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 0.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 3.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.4 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 1.8 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.6 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 1.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 5.1 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 1.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 2.2 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.1 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.1 | 0.7 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.3 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.0 | 0.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.2 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.0 | 0.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.1 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.0 | 0.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.3 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.0 | 0.2 | GO:0043291 | RAVE complex(GO:0043291) |
0.0 | 4.0 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 8.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 4.5 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 2.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 1.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 1.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 6.3 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 0.1 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.0 | 0.8 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 1.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 13.1 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 0.6 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.9 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 1.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 2.1 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.3 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 1.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0072372 | nonmotile primary cilium(GO:0031513) primary cilium(GO:0072372) |
0.0 | 2.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 2.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 1.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.2 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 0.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 3.1 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.0 | 0.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.3 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.0 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 10.1 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 2.8 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.0 | 1.3 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 2.5 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.4 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 0.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0033643 | host cell part(GO:0033643) |
0.0 | 1.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.0 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 2.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.1 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.0 | 0.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 1.7 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 2.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.0 | GO:0044448 | cell cortex part(GO:0044448) |
0.0 | 0.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 0.3 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.0 | 2.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 2.3 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 0.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.0 | 0.1 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 0.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 2.3 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 2.0 | GO:0044309 | neuron spine(GO:0044309) |
0.0 | 1.8 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 1.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.0 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.4 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.0 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.0 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 1.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.1 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 1.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.0 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.0 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 11.4 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.1 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.0 | 0.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.0 | GO:0032584 | growth cone membrane(GO:0032584) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 5.9 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
1.2 | 8.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.1 | 3.4 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
1.1 | 4.4 | GO:0035501 | MH1 domain binding(GO:0035501) |
1.0 | 14.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.0 | 3.0 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.8 | 3.0 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.7 | 6.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.7 | 2.0 | GO:0016768 | spermine synthase activity(GO:0016768) |
0.7 | 0.7 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.7 | 2.0 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.6 | 1.9 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.6 | 1.8 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.6 | 3.5 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.6 | 1.8 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.6 | 2.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.6 | 0.6 | GO:0070905 | serine binding(GO:0070905) |
0.5 | 3.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.5 | 1.6 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.5 | 1.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 2.0 | GO:0032427 | GBD domain binding(GO:0032427) |
0.5 | 1.5 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.5 | 3.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.5 | 3.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.5 | 7.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.5 | 2.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.5 | 0.5 | GO:0097001 | ceramide binding(GO:0097001) |
0.5 | 10.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.5 | 2.3 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.5 | 6.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.4 | 0.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.4 | 1.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 4.4 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.4 | 2.6 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.4 | 10.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.4 | 1.3 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.4 | 3.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.4 | 1.3 | GO:0031775 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
0.4 | 0.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 3.7 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.4 | 4.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.4 | 2.8 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.4 | 15.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.4 | 1.2 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
0.4 | 2.3 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.4 | 3.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 5.3 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.4 | 1.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 8.1 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.4 | 3.3 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 10.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 3.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.4 | 3.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.3 | 1.6 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.3 | 2.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 1.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.3 | 0.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 2.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 1.0 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.3 | 1.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 0.9 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 2.7 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.3 | 2.1 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.3 | 1.8 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.3 | 1.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 2.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 1.1 | GO:0008431 | vitamin E binding(GO:0008431) |
0.3 | 1.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 1.6 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.3 | 3.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 0.8 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 1.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 5.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 8.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 2.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 1.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 1.3 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.3 | 1.0 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.3 | 2.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 1.3 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.3 | 0.8 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.3 | 11.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 4.0 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.3 | 1.3 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.3 | 0.8 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.2 | 2.5 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.2 | 1.2 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
0.2 | 1.0 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.2 | 5.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.7 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.2 | 5.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 0.7 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.2 | 1.2 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.2 | 3.6 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 4.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 0.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 5.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 2.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.2 | 4.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 0.5 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.2 | 2.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 10.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 8.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 9.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 2.0 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 0.7 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.2 | 4.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 1.3 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.2 | 0.6 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
0.2 | 1.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.2 | GO:0039552 | RIG-I binding(GO:0039552) |
0.2 | 3.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 1.0 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 2.8 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 1.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 1.0 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.2 | 2.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 2.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 1.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 1.4 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.8 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.2 | 3.9 | GO:0030546 | receptor activator activity(GO:0030546) |
0.2 | 2.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 0.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 3.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 0.6 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.2 | 2.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.5 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
0.2 | 2.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 2.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 2.6 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 2.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 0.7 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.2 | 0.7 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.2 | 2.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 0.5 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.2 | 0.7 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.2 | 0.8 | GO:0032143 | single thymine insertion binding(GO:0032143) |
0.2 | 2.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) collagen receptor activity(GO:0038064) |
0.2 | 0.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 6.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.2 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.2 | 0.7 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.2 | 1.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 1.5 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 13.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.5 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 2.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 6.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 4.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 2.1 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.5 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.2 | 0.6 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.2 | 0.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 1.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 0.9 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.6 | GO:0004057 | arginyltransferase activity(GO:0004057) |
0.2 | 1.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 0.5 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.2 | 6.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.2 | 0.5 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.3 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 28.2 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 7.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 2.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 4.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.3 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.1 | 0.7 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 1.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.6 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.7 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
0.1 | 0.4 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.1 | 0.6 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.1 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.4 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.1 | 1.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.3 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.1 | 0.4 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.1 | 6.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 1.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 4.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 1.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.4 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.1 | 6.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
0.1 | 0.5 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 0.6 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.1 | 4.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 2.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.9 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.6 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.1 | 2.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 5.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 4.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 11.7 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.4 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.1 | 0.7 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 3.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 1.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.4 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
0.1 | 0.4 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.9 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.3 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.1 | 0.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.7 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 2.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 2.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 1.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 8.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 0.4 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.1 | 0.4 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.1 | 1.0 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.9 | GO:0042835 | BRE binding(GO:0042835) |
0.1 | 2.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 2.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 3.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 3.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 3.0 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 5.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 3.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 5.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 1.2 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 0.6 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.7 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.1 | 4.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 3.3 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 1.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 1.6 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 6.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 1.2 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 4.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.3 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
0.1 | 6.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 1.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.6 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.1 | 0.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 0.3 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.1 | 0.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.4 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.1 | 1.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.6 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 3.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.2 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.1 | 0.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.1 | 1.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 2.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.7 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.3 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
0.1 | 0.3 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 1.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 13.3 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.1 | 0.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 10.5 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.1 | 1.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.4 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.1 | 0.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.7 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.3 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.1 | 0.3 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.1 | 0.3 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
0.1 | 0.5 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 2.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 5.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 2.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 1.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 1.0 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.4 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.1 | 5.7 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.5 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 1.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 1.0 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 1.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 2.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.8 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.5 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.1 | 6.5 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.1 | 1.0 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 3.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 2.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 1.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 1.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 1.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 6.1 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 0.8 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.1 | 3.7 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.4 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
0.1 | 0.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 1.1 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.7 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 1.9 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.4 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 1.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.4 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.2 | GO:0086076 | gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling(GO:0086076) gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling(GO:0086078) gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling(GO:0086079) |
0.1 | 0.3 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.2 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.1 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 1.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 1.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.6 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.1 | 0.7 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 6.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.3 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 0.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 31.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.2 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.1 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.3 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 0.2 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.1 | 16.3 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 2.4 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
0.1 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 1.5 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.9 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 0.2 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
0.1 | 0.2 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.1 | 0.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 1.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 1.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.1 | 1.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.3 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.1 | 1.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.2 | GO:0001855 | complement component C4b binding(GO:0001855) |
0.1 | 2.2 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.2 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.1 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.5 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 7.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.3 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 2.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.6 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 6.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.7 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.2 | GO:0097003 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
0.1 | 0.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 2.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.3 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
0.1 | 0.3 | GO:0031208 | POZ domain binding(GO:0031208) |
0.1 | 0.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 1.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 4.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.0 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 4.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.1 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
0.0 | 0.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.0 | 0.7 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.0 | 1.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.0 | 2.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 1.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.4 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.5 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0061598 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.0 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.3 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.0 | 0.2 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.0 | 0.2 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.0 | 4.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.0 | 0.3 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 4.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.0 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.5 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.2 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 1.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.6 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.2 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) fatty acid peroxidase activity(GO:0047888) |
0.0 | 0.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.3 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 0.2 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.0 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 1.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.1 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.0 | 0.1 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.0 | 11.6 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.4 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.0 | 0.2 | GO:0050421 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
0.0 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.2 | GO:1902444 | riboflavin binding(GO:1902444) |
0.0 | 0.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 1.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 3.2 | GO:0019001 | guanyl nucleotide binding(GO:0019001) |
0.0 | 2.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.1 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
0.0 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 2.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 1.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.0 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.2 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.0 | 0.2 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.0 | 0.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.1 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0008398 | sterol 14-demethylase activity(GO:0008398) |
0.0 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.0 | 0.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 1.1 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0043532 | angiostatin binding(GO:0043532) |
0.0 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.0 | 0.1 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.0 | 0.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 2.1 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 1.1 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 6.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.1 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.0 | 0.0 | GO:0070026 | nitric oxide binding(GO:0070026) |
0.0 | 0.1 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.0 | 4.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.0 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.0 | 0.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.0 | 0.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.0 | 0.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.0 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.0 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.0 | 2.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.3 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.5 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.1 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.0 | 0.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.5 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.2 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.0 | 0.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0032557 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) pyrimidine ribonucleotide binding(GO:0032557) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
0.0 | 0.1 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.0 | 0.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 7.0 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 23.1 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.4 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 1.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0004920 | interferon-gamma receptor activity(GO:0004906) interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.5 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) folic acid receptor activity(GO:0061714) |
0.0 | 0.0 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.0 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.0 | 0.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.0 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.0 | 0.0 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.0 | 0.4 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 2.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.0 | GO:0030551 | cyclic nucleotide binding(GO:0030551) cAMP binding(GO:0030552) |
0.0 | 0.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.0 | 0.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 34.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 8.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 1.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 13.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 7.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 13.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 6.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 10.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 17.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 7.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 30.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 1.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 1.8 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 12.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 10.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 5.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 8.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 11.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 8.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 4.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 2.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 9.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 7.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 4.6 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 9.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 6.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 3.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 6.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 4.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 2.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 4.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 7.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 2.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 6.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 2.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 2.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 5.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 2.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 2.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.5 | PID ATM PATHWAY | ATM pathway |
0.1 | 3.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 4.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 1.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 2.0 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 2.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 1.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 5.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 3.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 7.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 1.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.5 | 22.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.5 | 7.6 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.5 | 6.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 8.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 3.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.4 | 9.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 9.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 3.5 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 3.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.3 | 8.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 10.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 6.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 17.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 2.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 2.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 6.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 5.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 0.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.2 | 0.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 7.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 2.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 15.1 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.2 | 6.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 11.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 0.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 3.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 2.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 6.2 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 2.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 4.9 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 3.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 3.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 4.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 2.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 2.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 4.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 4.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 3.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 5.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 3.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 2.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 6.4 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 2.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 10.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 1.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 11.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 1.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 2.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.7 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 2.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.1 | 6.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 3.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 2.0 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.9 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 3.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 2.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 3.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 2.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 1.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 3.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 21.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 11.0 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 2.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 1.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 6.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.1 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 0.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 1.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 1.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 1.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 3.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 1.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.9 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 2.0 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 1.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 3.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.5 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 0.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 1.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 1.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 3.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 1.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 3.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 1.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 2.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 1.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 7.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 0.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 1.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 4.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.8 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.2 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 1.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.0 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |